Physician profile
Jon E Highum
NPI 1538215603
$1,557.65
in general payments reported to CMS, 2019-2025
10 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $62.24 · 2021: $255 · 2022: $377 · 2023: $156 · 2024: $269 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.25 |
| Education | $190.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $507.19 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $417.63 | 2019-2025 | Uzedy, Austedo Xr, Austedo |
| Sunovion Pharmaceuticals INC. | $269.29 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $101.45 | 2019-2025 | Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $93.82 | 2021-2022 | |
| Alkermes, INC. | $42.92 | 2019-2025 | Lybalvi |
| Neurocrine Biosciences, INC. | $42.86 | 2019-2022 | |
| Indivior INC. | $41.15 | 2020-2024 | Perseris |
| Allergan, INC. | $27.19 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $14.15 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Highum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.